Understanding and treating metabolic issues in the brain after mild traumatic injuries
Investigating and treating metabolic deficits in the neurovascular unit following mild traumatic brain injury
This study looks at how mild brain injuries can impact brain health by affecting the blood-brain barrier and causing metabolic problems, with the goal of finding new treatments that could help people recover better after such injuries.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-11077863 on NIH RePORTER |
What this research studies
This research investigates how mild traumatic brain injuries (TBIs) affect the brain's neurovascular unit, which is crucial for maintaining brain health. It focuses on the breakdown of the blood-brain barrier and the resulting metabolic imbalances that can lead to conditions like Alzheimer's disease. By analyzing the metabolic deficits in brain cells and blood vessels, the study aims to identify potential therapeutic approaches using specific compounds that may restore normal function. Patients may benefit from insights into new treatments that target these metabolic issues following a mild TBI.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have suffered a mild traumatic brain injury and are experiencing cognitive or metabolic symptoms.
Not a fit: Patients who have not experienced a mild traumatic brain injury or those with advanced neurodegenerative diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve recovery and reduce the risk of dementia in patients who have experienced mild TBIs.
How similar studies have performed: Previous research has shown promising results in targeting metabolic dysfunctions in the brain, suggesting that this approach may lead to significant advancements in treatment.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Hubbard, William Brad — University of Kentucky
- Study coordinator: Hubbard, William Brad
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.